Welcome to LookChem.com Sign In|Join Free
  • or
2,2-diethoxy-1-(3-nitrophenyl)ethanone is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

134703-05-2

Post Buying Request

134703-05-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

134703-05-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 134703-05-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,4,7,0 and 3 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 134703-05:
(8*1)+(7*3)+(6*4)+(5*7)+(4*0)+(3*3)+(2*0)+(1*5)=102
102 % 10 = 2
So 134703-05-2 is a valid CAS Registry Number.

134703-05-2Downstream Products

134703-05-2Relevant academic research and scientific papers

One-pot synthesis of α-ketoacetals from aryl methyl ketones in the presence of selenous acid catalyzed by boron trifluoride etherate

Kharkongor, Icydora,Myrboh, Bekington

, p. 4359 - 4362 (2015)

A simple and efficient one-pot preparation of α-ketoacetals from substituted acetophenones and triethylorthoformate in the presence of H2SeO3 and BF3·Et2O as catalyst has been developed. The desired products are obtained in good yields by a simple protocol involving neat and mild reaction conditions. The present methodology provides an attractive alternative method for the preparation of α-ketoacetal derivatives.

[1,2,4]TRIAZOLO[4,3-B][1,2,4]TRIAZINE COMPOUND, PREPARATION METHOD AND USE THEREOF

-

Paragraph 0213; 0214, (2013/11/05)

The present invention relates to a structurally novel [1,2,4]triazolo[4,3-b][1,2,4]triazine compounds represented by formula (I) or formula (II), pharmaceutically acceptable salts thereof, prodrugs thereof, hydrates or solvates thereof, and also relates to a preparation method of the compounds, a pharmaceutical composition comprising a therapeutically effective amount of the compounds, as well as the use thereof as protein tyrosine kinase inhibitors, particularly as c-Met inhibitors, in the preparation of medicaments for the prevention and/or treatment of diseases associated with c-Met abnormality.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 134703-05-2